Key Laboratory of Radiation Physics and Technology of the Ministry of Education, Institute of Nuclear Science and Technology, College of Chemistry, Sichuan University, Chengdu 610064, China.
Inorg Chem. 2023 Mar 27;62(12):4922-4933. doi: 10.1021/acs.inorgchem.2c04384. Epub 2023 Mar 15.
An unmet challenge in the thorium-uranium fuel cycle is the efficient separation of uranium from thorium. Herein, two new tetradentate N,O-hybrid ligands, ,'-diethyl-,'-di--tolyl-2,2'-bipyridine-6,6'-dicarboxamide (Et-Tol-BPDA) and ,'-diethyl-,'-di--tolyl-2,2'-bipyrimidine-4,4'-dicarboxamide (Et-Tol-BPymDA), comprising a bipyridine or bipyrimidine core and amide moieties were designed and synthesized for selectively complexing and separating U(VI) from Th(IV). The high U(VI)/Th(IV) extraction selectivity was achieved by Et-Tol-BPDA ( = 33 at 3 M HNO) and Et-Tol-BPymDA ( = 73 at 3 M HNO) in nitric acid solutions. The extraction process for U(VI) or Th(IV) with these two ligands primarily proceeded through the solvation mechanism, as evidenced by slope analyses. Thermodynamic studies for the extraction of U(VI) and Th(IV) revealed a spontaneous process. Results from UV-vis spectroscopic titration and slope analyses demonstrated that U(VI) and Th(IV) each form a 1:1 complex with the two ligands both in the monophasic organic solution and the biphasic extraction system. The stability constants of the 1:1 complexes of Et-Tol-BPDA or Et-Tol-BPymDA with U(VI) were found to be larger than those with Th(IV), which coincide well with the high U(VI)/Th(IV) extraction selectivity. The solid-state structures of Et-Tol-BPDA, Et-Tol-BPymDA, and 1:1 complexes of the two ligands with U(VI) or Th(IV) were analyzed by X-ray diffraction technique. The results from this work implicate the potential of bipyridine- and bipyrimidine-derived diamide ligands for uranium/thorium separation.
钍-铀燃料循环中的一个未满足的挑战是有效地将铀与钍分离。在此,设计并合成了两种新的四齿 N,O-混合配体,,'-二乙基-,'-二--甲苯基-2,2'-联吡啶-6,6'-二羧酸酰胺(Et-Tol-BPDA)和,'-二乙基-,'-二--甲苯基-2,2'-联嘧啶-4,4'-二羧酸酰胺(Et-Tol-BPymDA),它们包含一个联吡啶或联嘧啶核和酰胺部分,用于选择性地络合和分离 U(VI)和 Th(IV)。在硝酸溶液中,Et-Tol-BPDA(在 3 M HNO 时 = 33)和 Et-Tol-BPymDA(在 3 M HNO 时 = 73)实现了高 U(VI)/Th(IV)萃取选择性。这两种配体萃取 U(VI)或 Th(IV)的过程主要通过溶剂化机制进行,这一点可以通过斜率分析得到证明。对于 U(VI)和 Th(IV)的萃取热力学研究表明这是一个自发的过程。UV-vis 光谱滴定和斜率分析的结果表明,U(VI)和 Th(IV)在单相有机溶液和两相萃取体系中均与两种配体形成 1:1 络合物。发现 Et-Tol-BPDA 或 Et-Tol-BPymDA 与 U(VI)形成的 1:1 络合物的稳定常数大于与 Th(IV)形成的稳定常数,这与高的 U(VI)/Th(IV)萃取选择性吻合较好。通过 X 射线衍射技术分析了 Et-Tol-BPDA、Et-Tol-BPymDA 以及两种配体与 U(VI)或 Th(IV)形成的 1:1 络合物的固体结构。这项工作的结果表明,基于联吡啶和联嘧啶的二酰胺配体具有铀/钍分离的潜力。